Literature DB >> 33647322

Similarities in alcohol and opioid withdrawal syndromes suggest common negative reinforcement mechanisms involving the interoceptive antireward pathway.

Sean J O'Sullivan1, James S Schwaber2.   

Abstract

Alcohol and opioids are two major contributors to so-called deaths of despair. Though the effects of these substances on mammalian systems are distinct, commonalities in their withdrawal syndromes suggest a shared pathophysiology. For example, both are characterized by marked autonomic dysregulation and are treated with alpha-2 agonists. Moreover, alcohol and opioids rapidly induce dependence motivated by withdrawal avoidance. Resemblances observed in withdrawal syndromes and abuse behavior may indicate common addiction mechanisms. We argue that neurovisceral feedback influences autonomic and emotional circuits generating antireward similarly for both substances. Amygdala is central to this hypothesis as it is principally responsible for negative emotion, prominent in addiction and motivated behavior, and processes autonomic inputs while generating autonomic outputs. The solitary nucleus (NTS) has strong bidirectional connections to the amygdala and receives interoceptive inputs communicating visceral states via vagal afferents. These visceral-emotional hubs are strongly influenced by the periphery including gut microbiota. We propose that gut dysbiosis contributes to alcohol and opioid withdrawal syndromes by contributing to peripheral and neuroinflammation that stimulates these antireward pathways and motivates substance dependence.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alcohol; Amygdala; Gut-brain axis; Inflammation; Microbiome; Opioid; Substance use disorders; Withdrawal

Mesh:

Substances:

Year:  2021        PMID: 33647322      PMCID: PMC8555739          DOI: 10.1016/j.neubiorev.2021.02.033

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   9.052


  97 in total

Review 1.  The relationship between opioid and sugar intake: review of evidence and clinical applications.

Authors:  David J Mysels; Maria A Sullivan
Journal:  J Opioid Manag       Date:  2010 Nov-Dec

2.  The Treatment of Obesity and Its Co-occurrence with Substance Use Disorders.

Authors:  Katherine A Vanbuskirk; Marc N Potenza
Journal:  J Addict Med       Date:  2010-03       Impact factor: 3.702

Review 3.  Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits.

Authors:  Karina P Abrahao; Armando G Salinas; David M Lovinger
Journal:  Neuron       Date:  2017-12-20       Impact factor: 17.173

Review 4.  Induction of innate immune genes in brain create the neurobiology of addiction.

Authors:  F T Crews; Jian Zou; Liya Qin
Journal:  Brain Behav Immun       Date:  2011-03-21       Impact factor: 7.217

5.  The role of TNFα in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats.

Authors:  Shuanglin Hao; Shue Liu; Xuexing Zheng; Wenwen Zheng; Handong Ouyang; Marina Mata; David J Fink
Journal:  Neuropsychopharmacology       Date:  2010-11-10       Impact factor: 7.853

6.  GLP-1 influences food and drug reward.

Authors:  Matthew R Hayes; Heath D Schmidt
Journal:  Curr Opin Behav Sci       Date:  2016-06

Review 7.  Autoimmune diseases, gastrointestinal disorders and the microbiome in schizophrenia: more than a gut feeling.

Authors:  Emily G Severance; Robert H Yolken; William W Eaton
Journal:  Schizophr Res       Date:  2014-07-15       Impact factor: 4.939

8.  The vagus nerve mediates the suppressing effects of peripherally administered oxytocin on methamphetamine self-administration and seeking in rats.

Authors:  Nicholas A Everett; Anita J Turner; Priscila A Costa; Sarah J Baracz; Jennifer L Cornish
Journal:  Neuropsychopharmacology       Date:  2020-05-25       Impact factor: 7.853

9.  Acute morphine alters GABAergic transmission in the central amygdala during naloxone-precipitated morphine withdrawal: role of cyclic AMP.

Authors:  Michal Bajo; Samuel G Madamba; Marisa Roberto; George R Siggins
Journal:  Front Integr Neurosci       Date:  2014-06-04

Review 10.  Gut microbiota: Implications in Parkinson's disease.

Authors:  Arun Parashar; Malairaman Udayabanu
Journal:  Parkinsonism Relat Disord       Date:  2017-02-07       Impact factor: 4.891

View more
  1 in total

Review 1.  The Convergent Neuroscience of Affective Pain and Substance Use Disorder.

Authors:  Amanda R Pahng; Scott Edwards
Journal:  Alcohol Res       Date:  2021-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.